Sarah Koscica
Family Medicine · Peoria, ILNPI 1003814625
Payments from drug & device makers
Across 289 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Preventric Diagnostics, Inc.$710
- AbbVie$675
- Abbott$523
- Pfizer$479
- Gilead$362
- Bayer$354
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Preventric Diagnostics, Inc. | 1 | $710 |
| AbbVie | 39 | $675 |
| Abbott | 28 | $523 |
| Pfizer | 32 | $479 |
| Gilead | 23 | $362 |
| Bayer | 23 | $354 |
| GSK | 26 | $311 |
| AstraZeneca | 14 | $298 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $250 |
| Otsuka America Pharmaceutical, Inc. | 11 | $236 |
| Sanofi Pasteur Inc. | 11 | $225 |
| Dexcom, Inc. | 3 | $216 |
| Xeris Pharmaceuticals, Inc. | 11 | $209 |
| Teva Pharmaceuticals USA, Inc. | 5 | $189 |
| Merck | 8 | $183 |
| Novartis | 5 | $106 |
| Phadia US Inc. | 4 | $87 |
| Johnson & Johnson | 3 | $73 |
| E.r. Squibb & Sons, L.L.C. | 3 | $68 |
| Novo Nordisk | 5 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $60 |
| Ironshore Pharmaceuticals Inc. | 3 | $54 |
| Neurocrine Biosciences, Inc. | 2 | $49 |
| Sanofi-aventis U.S. LLC | 3 | $45 |
| Amgen | 2 | $34 |
| Lilly USA, LLC | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
| Insulet Corporation | 1 | $16 |
| Shire North American Group Inc | 1 | $11 |
| Echosens North America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,017 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 191 | $210,000 |
| JardianceEmpagliflozin | 176 | $158,436 |
| OzempicSemaglutide | 79 | $89,031 |
| EliquisApixaban | 70 | $66,951 |
| JanuviaSitagliptin Phosphate | 39 | $51,976 |
| FarxigaDapagliflozin Propanediol | 54 | $41,219 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $27,498 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 67 | $21,840 |
| TradjentaLinagliptin | 30 | $19,262 |
| Aripiprazole | 11 | $15,489 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $14,162 |
| XareltoRivaroxaban | 26 | $14,042 |
| Spiriva HandihalerTiotropium Bromide | 11 | $13,436 |
| InvokanaCanagliflozin | 11 | $12,161 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $12,102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $30 | $210,000191 claims |
| Novo NordiskOzempic | $64 | $89,03179 claims |
| PfizerEliquis | $479 | $66,95170 claims |
| MerckJanuvia, Dulera | $183 | $58,53056 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Shingrix | $311 | $52,047112 claims |
| AstraZenecaFarxiga, Symbicort | $298 | $50,09979 claims |
| Johnson & JohnsonXarelto, Invokana | $73 | $26,20337 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Peoria
- David TrachtenbargPeoria$304K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.